Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
E. Sally Ward, Deborah Gelinas, Erwin Dreesen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The therapeutic age of the neonatal Fc receptor
Michał Pyzik, Lisa K. Kozicky, Amit Gandhi, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 7, pp. 415-432
Open Access | Times Cited: 107
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
James F. Howard, Vera Bril, Tuan Vu, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 23
Novel Immunotherapies for Myasthenia Gravis
Sruthi Nair, Saiju Jacob
ImmunoTargets and Therapy (2023) Vol. Volume 12, pp. 25-45
Open Access | Times Cited: 39
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis
Carlo Antozzi, Jeffrey T. Guptill, Vera Bril, et al.
Neurology (2023) Vol. 102, Iss. 2
Open Access | Times Cited: 25
Batoclimab vs Placebo for Generalized Myasthenia Gravis
Chong Yan, Yao-Xian Yue, Yuzhou Guan, et al.
JAMA Neurology (2024) Vol. 81, Iss. 4, pp. 336-336
Closed Access | Times Cited: 12
Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+)
James F. Howard, Tuan Vu, George Li, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 5, pp. e00378-e00378
Closed Access | Times Cited: 10
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
Carlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.
The Lancet Neurology (2025) Vol. 24, Iss. 2, pp. 105-116
Closed Access | Times Cited: 1
Reducing IgG accumulation via neonatal Fc receptor (FcRn) blockade relieves neuropathic pain
Nathan T. Fiore, Kendal F. Willcox, Dorsa Dayani, et al.
Brain Behavior and Immunity (2025)
Open Access | Times Cited: 1
Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys
Ornella Binazon, Mario Cocco, Daniel Thwaites, et al.
Journal of Immunotoxicology (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Quantification of clesrovimab, an investigational, half-life extended, anti-respiratory syncytial virus protein F human monoclonal antibody in the nasal epithelial lining fluid of healthy adults
Jia Yao Phuah, Brian M. Maas, Aimin Tang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115851-115851
Open Access | Times Cited: 17
Autoimmune thyroid disease and myasthenia gravis: a study bidirectional Mendelian randomization
Suijian Wang, Kui Wang, Xiaohong Chen, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 7
Association between protein intake, serum albumin and blood eosinophil in US asthmatic adults
Jun Wen, Jing Xia, Qingliu He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
FcRn inhibitors: a novel option for the treatment of myasthenia gravis
Lina Zhu, Haiman Hou, Sai Wang, et al.
Neural Regeneration Research (2022)
Open Access | Times Cited: 27
Blood–urea–nitrogen-to-serum–albumin ratio in predicting the value of patients with contrast-induced nephropathy for coronary heart disease
Qiong Pan, Yanchun Peng, Ní Hóng, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 6, pp. 2075-2083
Closed Access | Times Cited: 5
FcRn Inhibitor Therapies in Neurologic Diseases
Nouf Alfaidi, Salama Karmastaji, Alexandria Matic, et al.
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 425-441
Closed Access | Times Cited: 5
Missing Regulation Between Genetic Association and Transcriptional Abundance for Hypercholesterolemia Genes
Aaron Hakim, Noah J Connally, Gavin R. Schnitzler, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 84-84
Open Access
Association between macular vessel density and microvascular biomarkers in pediatric chronic kidney disease
E. Mohamed, Samira Sayed, Lamia H. Ali, et al.
Journal of the Egyptian Ophthalmological Society (2025) Vol. 118, Iss. 1, pp. 43-54
Open Access
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
Alan Chun Hong Lee, George J. Kahaly
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
Torleif Tollefsrud Gjølberg, Simone Mester, Gaia Calamera, et al.
BioDrugs (2025)
Open Access
Safety and effectiveness of efgartigimod for intravenous infusion in patients with generalized myasthenia gravis: an interim analysis of Japanese post-marketing surveillance
Hirofumi Teranishi, Koichi Tsuda, Ryu Kanzaki, et al.
Expert Opinion on Biological Therapy (2025)
Open Access
The impact of inflammation and acute phase activation in cancer cachexia
Tyler P. Robinson, Tewfik Hamidi, Brittany R. Counts, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin
Guanglong Ma, Andrew R. Crowley, Liesbeth Heyndrickx, et al.
JCI Insight (2024) Vol. 9, Iss. 10
Open Access | Times Cited: 4
Association between serum albumin and asthma in the general population of the United States: a retrospective study based on NHANES 2003–2018
Bingxin Song, Chenqi Jin, Ning Li
Journal of Asthma (2025), pp. 1-9
Closed Access
ADAPT NXT: Fixed Cycles or Every‐Other‐Week IV Efgartigimod in Generalized Myasthenia Gravis
Ali A. Habib, Kristl G. Claeys, Vera Bril, et al.
Annals of Clinical and Translational Neurology (2025)
Open Access
Therapeutic Plasma Exchange Versus FcRn Inhibition in Autoimmune Disease
Paola Mina‐Osorio, Minh‐Ha Tran, Ali A. Habib
Transfusion Medicine Reviews (2023) Vol. 38, Iss. 1, pp. 150767-150767
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top